1910 results for Leukemia

Refine Your Search

Ask the Expert: Acute Myeloid Leukemia (AML)

Ask the Expert: Acute Myeloid Leukemia (AML)

Video coming soon. Topics CoveredPatients and care partners will have an opportunity to connect directly with an acute myeloid leukemia (AML) speciali…

Overcoming RAS-driven Mechanisms of Resistance in Leukemia

The protein kinase (MAPK) pathway is activated in leukemia and is a hallmark of resistance to therapies. This project uses xenograft models of rela…

Chronic lymphocytic leukemia (CLL) treatment

While there is no cure, there are several approaches and treatments that chronic lymphocytic leukemia (CLL) specialists can use to help manage CLL.

Blood Cancer

DNA damage, immune response, aging and leukemia

Hematopoiesis is tightly regulated by intrinsic and extrinsic signals, alterations of which can affect hematopoietic stem cell (HSC) function and lead…

Suggested Reading - A Brave Kid’s Guide to Leukemia

Suggested Reading - A Brave Kid’s Guide to Leukemia

A Brave Kid’s Guide to Leukemia by Nina Gonzalez, MDHello Brave Co, , Pages, PaperbackISBN: -8990710511Charlie is a curious kid facing a big challeng…

A Discussion on Strategies for New Therapies and Evolving Care in Chronic Lymphocytic Leukemia (CLL)

Event Details Wednesday, November , : PM – : PM ET12: PM – : PM CT11: AM – : PM MT10: AM – : AM PT Program Slides:Download FormatLive Inte…

FDA Approves New Option for Difficult to Treat, Rare Form of Childhood Leukemia

FDA Approves New Option for Difficult to Treat, Rare Form of Childhood Leukemia

The Food and Drug Administration (FDA) recently approved azacitidine (Vidaza®) for pediatric patients month and older with newly diagnosed juvenile m…

FDA Approves First CAR T-Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

FDA Approves First CAR T-Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

The U.S. Food and Drug Administration (FDA) recently announced approval of brexucabtagene autoleucel (Tecartus®) as the first and only CAR treatment …

Chronic Myeloid Leukemia (CML): Current Strategies & Insights

Chronic Myeloid Leukemia (CML): Current Strategies & Insights

Topics CoveredWe invite you to learn more about:How chronic myeloid leukemia (CML) is treatedTreatment goals and monitoring for CMLManaging side effec…

Education Resources

Leukemia, Lymphoma, Hodgkin’s Disease & Myeloma Support Group - Middletown

The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…

Understanding Leukemia in Children with Down Syndrome to Develop Better Therapies

This Specialized Center of Research is focused on identifying the contributions of chromosome , which is present in three copies in individuals with D…

Leveraging p53 to Improve Menin Inhibition in Leukemia Therapy

Acute myeloid leukemia remains a highly lethal disease. Menin inhibitors are an exciting new class of drugs in leukemic but are rarely curative and ha…

Developing novel therapeutic approaches for classical and variant hairy cell leukemia

In this proposal, we have combined clinical and research expertise in HCL across Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College…

Targeting Leukemia Stem Cells with the Novel Antibody Drug Conjugate

To improve the cure rate of patients suffering from acute myeloid leukemia (AML), our study aims to target resistant leukemia stem cells by developing…

Chronic myeloid leukemia (CML)

Chronic myeloid leukemia (CML) is a cancer of the bone marrow and blood CML is usually diagnosed in its chronic phase when treatment is very effective…

Blood Cancer

Suggested Reading - Adult Leukemia: A Comprehensive Guide for Patients and Families

Adult Leukemia: A Comprehensive Guide for Patients and Families By Barbara Lackritz O'Reilly & Associates Inc., , pages ISBN: This guide provi…

Suggested Reading - Adult Leukemia: A Comprehensive Guide for Patients and Families

Adult Leukemia: A Comprehensive Guide for Patients and Families By Barbara Lackritz O'Reilly & Associates Inc., , pages ISBN: This guide provi…

Targeted combination therapies for leukemia with NUP98 translocations

Leukemia patients with chromosomal translocations of the Nucleoporin (NUP98) gene suffer from very poor prognosis. In this project we will identify ne…

The Leukemia & Lymphoma Society Still Reins “Superior” in Independent Analysis of Chronic Disease Nonprofits

The Leukemia & Lymphoma Society Still Reins “Superior” in Independent Analysis of Chronic Disease Nonprofits

LLS continues to sustain bold progress, maintaining Cause Reports highest score and earned an esteemed "Superior" rating in its new, independent analy…

The Leukemia & Lymphoma Society Still Reigns “Superior” in Independent Analysis of Chronic Disease Nonprofits

The Leukemia & Lymphoma Society Still Reigns “Superior” in Independent Analysis of Chronic Disease Nonprofits

LLS continues to sustain bold progress, maintaining Cause Reports highest score and earned an esteemed "Superior" rating in its new, independent analy…

Epigenetic Mechanisms in Acute Myeloid Leukemia

The goal of this project is to investigate the role of the epigenetic regulator (ENL) and its cancer mutations in acute myeloid leukemia (AML). Our s…

T-cell prolymphocytic leukemia (T-PLL)

prolymphocytic leukemia () is an extremely rare and typically aggressive cancer characterized by the growth of mature T cells (). T cells are a type …

Blood Cancer

Understanding Your Diagnosis: Acute Myeloid Leukemia (AML)

Understanding Your Diagnosis: Acute Myeloid Leukemia (AML)

Topics CoveredWe invite you to learn more about:New treatments for managementThe importance of clinical trials for AMLSpeakerEunice S. Wang MDChief, …

Investigating and targeting the histone acetylation reader protein ENL in acute leukemias

Leukemia often results from aberrant gene expression caused by epigenetic alterations. Previously we discovered a novel histone acetylation reader dom…